Burnett, Bruce Kendall
(919) 624-2167
bruce.burnett@duke.edu
701 W Main Street, Suite 500
Durham, NC 27701
Duke Box 90535
Durham, NC 27715

Webpages

Courses

CRP 254: Research Management

Bruce Kendall Burnett

Associate Professor in Medicine
Associate Professor in Medicine
Associate Professor in Medicine
Associate Professor in Medicine
Assistant Professor in Medicine
Core Faculty in Innovation & Entrepreneurship
Core Faculty in Innovation & Entrepreneurship
Member of the Duke Clinical Research Institute
I am the Director of Regulatory Affairs within the Duke Translational Medicine Institute.  This function provides regulatory, quality and preclinical GLP support for investigators here at Duke.

Education

  • Other, Harvard Medical School (1986)
  • Other, Harvard Medical School (1986)
  • Ph.D., Massachusetts Institute of Technology (1982)

Publications

Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical Trials. (01/2017)
Preclinical toxicity evaluation of a novel immunotoxin, D2C7-(scdsFv)-PE38KDEL, administered via intracerebral convection-enhanced delivery in rats. (04/2016)
ClinicalTrials.gov reporting: strategies for success at an academic health center. (02/2015)
Comprehensive hands-on training for influenza vaccine manufacturing: A WHO-BARDA-BTEC partnership for global workforce development (01/2014)
Comprehensive hands-on training for influenza vaccine manufacturing: a WHO-BARDA-BTEC partnership for global workforce development. (01/2014)
Warning letters to sponsor-investigators at academic health centres - the regulatory "canaries in a coal mine". (12/2013)
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients. (08/2013)
Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012. (08/2013)
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients (01/2013)
Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects. (11/2012)

Mailing Address

Nicholas Institute for Energy, Environment & Sustainability
Box 90467
Durham, NC 27708

Street / Delivery Address

Nicholas Institute for Energy, Environment & Sustainability
140 Science Drive
Gross Hall, Suite 101
Durham, NC 27708

919-613-1305